Explore liraglutide dosage trends, reconstitution volumes, and vial size patterns from WPA peptide calculator sessions for the only daily-injectable GLP-1 agonist.
Liraglutide is the only daily-injectable GLP-1 receptor agonist that has been formally approved, marketed as Victoza for type 2 diabetes and Saxenda for chronic weight management. This data captures the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting liraglutide.
2 Liraglutide reconstitution calculations have been logged by the WPA community. The most common dose entered is 300mcg (1 calculations). The median dose across all sessions is 600mcg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 10mg (2 sessions).
World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.